6/30/2021Review of Drug Approvals under the Priority Review and Breakthrough Pa...

6/30/2021Listed Domestic Pharma Cos See Sharp Performance Growth in Q1

6/30/2021Chinese Enteral Nutrition Market Predicted to Rise 2021-2025 and Beyon...

6/30/2021Financial-related Company News in Brief

6/30/2021China Further Deepens Healthcare Reform with A New Wave of Initiatives...

6/29/2021Innovent Granted Chinese Approval of TYVYT in Combo with BYVASDA as...

6/29/2021CDE Publicizes the List of Reference Formulations for GQCE Studies (46...

6/29/2021Vivoryon and Simcere Announce Licensing Deal for N3pE Amyloid-targetin...

6/28/2021China Issues the Medium- and Long-Range Development Plan for Medical I...

6/28/2021NHC Issues the Management Parameters for Rationalized Clinical Applica...

6/28/2021WuXi STA Plans Pharmaceutical Chemical Facility in Delaware

6/28/2021InnoCare Announces Breakthrough Therapy Designation of Orelabrutinib b...

6/28/2021J&J Partner Legend Plans JV Facility in Belgium as Its CAR-T Cilta-cel...

6/28/2021Innovent Announces License Agreement with Synaffix in an ADC Technolog...

6/28/2021Lonza Invests in Facility in China

6/28/2021Junshi Biosciences Announces NMPA Acceptance of IND Application for JS...

6/28/2021PharmaDJ's China Biotech Fundraising Tracker: April 2021

6/28/2021Latest Developments on Data Supplementation for Chemical or Pharmaceut...

6/25/2021AZ's Pulmicort, Bayer's Xarelto Among Big Losers in China's Largest Ro...

6/25/2021Innovent Releases Results of a Phase 1 Clinical Study of IBI362 in Ove...

6/25/2021NMPA Issues the List of Reference Formulations for GQCE Studies (42nd ...

6/25/2021CDE Issues the Technical Guidelines for Pharmaceutic Change Studies of...

6/24/2021CStone Announces Positive GAVRETO (Pralsetinib) Registrational Study D...

6/24/2021NMPA Issues the Provisions for Registration of Licensed Pharmacists

6/24/2021China Concludes the 5th Round of National Level VBP, Slashing Average ...

6/24/2021NMPA Revises Packages Insert of Oxiracetam Formulations and Injectable...

6/24/2021CDE's Annual Review of Chinese Drug Evaluation and Registration in 202...

6/24/2021Pharmaceuticals and APIs - Biden Admin Issues 100-Day Supply Chain Rev...

6/23/2021Online Platform Operator Medlive Tech Advances Plans for Hong Kong IPO

6/23/2021HUTCHMED's Orpathys Conditionally Approved in China for NSCLC

Page:202/795 Total number of articles:23848: [First][<<] [200] [201] [202] [203] [204] [>>] [End]